Actavis Keeps Trial Win In Man's Heart Attack Suit
An Illinois federal judge on Saturday refused to unwind Actavis' trial win over allegations that the company's Androderm testosterone drug caused a man's heart attack, saying that while Actavis' disclosure of...To view the full article, register now.
Already a subscriber? Click here to view full article